Biopharmaceuticals comprise therapeutic protein-based, nucleic acids and cell-based
products. According to their therapeutic success, the clinical use of these products has been
growing. Therefore, the development of efficient biopharmaceuticals delivery systems, which
overcome their limitations for administration, remains an excellent prospect for
pharmaceutical technologists. In this area, lipid nanoparticles have been increasingly
recognized as one of the most promising delivery systems, due to their exclusive …